A detailed history of Defender Capital, Llc. transactions in Johnson & Johnson stock. As of the latest transaction made, Defender Capital, Llc. holds 1,266 shares of JNJ stock, worth $184,646. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,266
Holding current value
$184,646
% of portfolio
0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$145.48 - $167.38 $184,177 - $211,903
1,266 New
1,266 $205,000
Q1 2024

May 06, 2024

BUY
$155.22 - $162.74 $197,284 - $206,842
1,271 New
1,271 $201,000
Q2 2023

Jul 18, 2023

BUY
$154.35 - $166.11 $463 - $498
3 Added 0.22%
1,369 $226,000
Q4 2021

Feb 01, 2022

BUY
$155.93 - $173.01 $213,000 - $236,331
1,366 New
1,366 $234,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Defender Capital, Llc. Portfolio

Follow Defender Capital, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Defender Capital, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Defender Capital, Llc. with notifications on news.